Adherence with isoniazid for prevention of tuberculosis among HIV-infected adults in South Africa

BMC Infectious Diseases

Volumn 6, Issue , 2006, Pages

  Szakacs, Tom A ^a   Wilson, Douglas ^b   Cameron, D William ^b   Clark, Michael ^a   Kocheleff, Paul ^b   Muller, F James ^b   McCarthy, Anne E ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

^b GREY'S HOSPITAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG METABOLITE; ISONIAZID; PYRIDOXINE;

ADULT; ARTICLE; CONFIDENCE INTERVAL; COST EFFECTIVENESS ANALYSIS; DISEASE ASSOCIATION; DRUG DETERMINATION; DRUG SAFETY; FEMALE; HEALTH BELIEF; HEALTH CARE AVAILABILITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; OPPORTUNISTIC INFECTION; PATIENT COMPLIANCE; PHARMACY; PREDICTION; QUESTIONNAIRE; SELF REPORT; SOUTH AFRICA; TEST STRIP; TUBERCULOSIS; TUBERCULOSIS CONTROL; UNIVARIATE ANALYSIS; URINALYSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTITUBERCULAR AGENTS; DRUG ADMINISTRATION SCHEDULE; HIV INFECTIONS; HUMANS; ISONIAZID; PATIENT COMPLIANCE; SOUTH AFRICA; TUBERCULOSIS, PULMONARY;

EID: 33746166015     PISSN: 14712334     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-6-97     Document Type: Article

References (28)

1. Corbett EL, Watt CJ, Walker N, Maher D, Williams BG, Raviglione MC, Dye C: The growing burden of tuberculosis. Arch Intern Med 2003, 163:1009-1021.
2. World Health Organization: Preventive therapy against tuberculosis in people living with HIV. Wkly Epidemiol Rec 1999, 74:385-398.
3. American Thoracic Society: Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection. Am J Respir Crit Care Med 2000, 161:S221-247.
4. Schraufnagel DE, Stoner R, Whitting E, Snust-Torbeck G, Werhane MJ: Testing for isoniazid. Chest 1990, 98(2):314-316.
5. Eidlitz-Markus T, Zeharia A, Baum G, Mimouni M, Amir J: Use of the urine color test to monitor compliance with isoniazid treatment of latent tuberculosis infection. Chest 2003, 123(3):736-739.
6. Meissner PE, Musoke P, Okwera A, Bunn JEG, Coulter JBS: The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda. Int J Tuberc Lung Dis 2002, 6(70):903-908.
7. Skukla SJ, Warren DK, Woeltje KF, Gruber CA, Fraser VJ: Factors associated with the treatment of latent tuberculosis infection among health-care workers at a midwestern teaching hospital. Chest 2002, 122(5):1609-1614.
8. Perry S, Hovell MF, Blumberg E, Berg J, Vera A, Sipan C, Kelley N, Moser K, Catanzaro A, Friedman L: Urine testing to monitor adherence to TB preventive therapy. J Clin Epidemiol 2002, 55:235-238.
9. Pekovic V, Mayanja H, Vjecha M, Johnson J, Okwera A, Nsubuga P, Mugerwa R, Ellner J, Whalen C: Comparison of three composite compliance indices in a trial of self-administered preventive therapy for tuberculosis in HIV-infected Ugandan adults. J Clin Epidemiol 1998, 51(7):597-607.
10. Lugada ES, Watera C, Nakiyingi J, Elliot A, Brink A, Nanyungja M, French N, Antivelink L, Gilks C, Whitworth J: Operational assessment of isoniazid prophylaxis in a community AIDS service organisation in Uganda. Int J Tuberc Lung Dis 2002, 6(4):326-331.
11. Aisu T, Raviglione MC, van Praag E, Eriki P, Narain JP, Barugahare L, Tembo G, McFarland D, Engwau FA: Preventive chemotherapy for HIV-associated tuberculosis in Uganda: an operational assessment at a voluntary counselling and testing centre. AIDS 1995, 9:267-273.
12. Hawken MP, Meme HK, Elliott LC, Chakaya JM, Morris JS, Githui WA, Juma ES, Odhiambo JA, Thiong'o LN, Kimari JN, Ngugi EN, Bwayo JJ, Gilks CF, Plummer FA, Porter JD, Nunn PP, McAdam KP: Isoniazid preventive therapy for tuberculosis in HIV-I-infected adults: results of a randomized controlled trial. AIDS 1997, 11:875-882.
13. Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P: Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai, Thailand. AIDS 1997, 11:107-112.
14. Elizaga J, Friedland JS: Monitoring compliance with antituberculous treatment by detection of isoniazid in urine. Lancet 1997, 350:1225-1226.
15. Kilburn JO, Beam RE, David HL, Sanchez E, Corpe RF, Dunn W: Reagent-impregnated paper strip for detection of metabolic products of isoniazid in urine. Am Rev Respir Dis 1972, 106:923-924.
16. LoBue PA, Moser KS: Use of isoniazid for latent tuberculosis infection in a public health clinic. Am J Respir Crit Care Med 2003, 168(4):443-447.
17. Rideout M, Menzies R: Factors affecting compliance with preventive treatment for tuberculosis at Mistassini Lake, Quebec, Canada. Clin Invest Med 1994, 17(1):31-36.
18. Hovell M, Blumber E, Gil-Trejo L, Vera A, Kelley N, Sipan C, Blumberg EJ, Carrizosa CM, Rovniak L: Predictors of adherence to treatment for latent tuberculosis infection in high-risk Latino adolescents: A behavioural epidemiological analysis. Soc Sci Med 2003, 56(8):1789-96.
19. Sumartojo E: When tuberculosis treatment fails: A social behavioural acount of patient adherence. Am Rev Respir Dis 1993, 147:1311-1320.
20. Westaway MS, Wolmarans L: Cognitive and affective reactions of black urban South Africans toward tuberculosis. Tubercl and Lung Dis 1994, 75:447-453.
21. Whatman International Ltd., grade 41 circular filter paper, Maidstone, England.
22. Churchyard GJ, Fielding K, Charalambous S, Day JS, Corbett EL, Hayes RJ: Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? AIDS 2003, 17:2063-2070.
23. Fitzgerald DW, Desvarieux M, Severe P, Joseph P, Johnson WD Jr, Pape JW: Effect of post-treatment isoniazid on prevention of recurrent tuberculosis in HIV-I-infected individuals: a randomized trial. Lancet 2002, 356:1470-1474.
24. Sonnenberg P, Murray J, Glynn JR, Shearer S, Kambashi B, Godfrey-Faussett P: HIV-I and recurrence, relapse, and reinfection of tuberculosis aftercure: a cohort study in South African mineworkers. Lancet 2001, 358:1687-1693.
25. Gurumurthy P, Ramachandran G, Hemanth Kumar AK, Rajasekaran S, Padmapriyadarsini C, Swaminathan S, Bhagavathy S, Venkatesan P, Sekar L, Mahilmaran A, Ravichandran N, Paramesh P: Malabsorption of rifampin and isoniazid in HIV-infected patients with and without tuberculosis. Clin Infect Dis 2004, 38(2):280-283.
26. Choudhri SH, Hawken M, Gathua S, Minyiri GO, Watkins W, Sahai J, Sitar DS, Aoki FY, Long R: Pharmacokinetics of antimycobacterial drugs in patients with tuberculosis, AIDS, and diarrhea. Clin Infect Dis 1997, 25(1):104-11.
27. Sahai J, Gallicano K, Swick L, Tailor S, Garber G, Seguin I, Oliveras L, Walker S, Rachlis A, Cameron DW: Reduced plasma concentration of antituberculosis drugs in patients with HIV infection. Ann Intern Med 1997, 127:289-293.
28. Fallab-Stubi C-L, Zellweger JP, Sauty A, Uldry C, Iorillo D, Burnier M: Electronic monitoring of adherence to treatment in the preventive chemotherapy of tuberculosis. Int J Tuberc Lung Dis 1998, 2(7):525-530.